With 900 advanced therapies currently under investigation and an expected 10 to 20 new therapy approvals each year from 2025 onwards, cell & gene therapy is going fast. But, it brings its own set of unique challenges to adapt.
Investing in Cell and Gene Therapies (CGT) – Future and Development
Binocs is pleased to announce the appointment of Akshay Peer (Ph.D.). As a co-founder of TrakCel, Akshay has spent his last 8 years working closely with a large number of CGT developers and associated organizations. He was instrumental in growing the company from 2 employees......